Opaleye Management Inc. 13D and 13G filings for TRACON Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 4:05 pm Sale |
2023-12-31 | 13D | TRACON Pharmaceuticals, Inc. TCON |
Opaleye Management Inc. | 0 0.000% |
-125,919 (Position Closed) |
Filing |
| 2021-02-12 5:20 pm Purchase |
2020-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Opaleye Management Inc. | 125,919 17.040% |
125,919 (New Position) |
Filing |